Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of DA-5219 in Patients With Acute or Chronic Gastritis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating DA-5219 for acute and chronic gastritis has completed; the snippet does not include trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastritis

Drugs mentioned

• DA-5219

Snippet

Sponsor: Dong-A ST Co., Ltd. | Conditions: Gastritis Acute, Gastritis Chronic | Phase 3 | Status: COMPLETED